These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6320023)

  • 1. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
    Hory B; Henriet MT
    Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the activity of plasma renin and blood aldosterone and in that of the enzyme converting angiotensin I to angiotensin II during the dialytic treatment of patients with chronic renal insufficiency].
    Novo S; Adamo L; Forte G; Galfano G; Giamporcaro A; Ferrara D; Strano A
    Cardiologia; 1985 Jul; 30(7):505-10. PubMed ID: 3011264
    [No Abstract]   [Full Text] [Related]  

  • 3. The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
    Krämer BK; Ress KM; Ulshöfer TM; Risler T
    Nephrol Dial Transplant; 1987; 2(6):531-6. PubMed ID: 3126454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis.
    Letizia C; Mazzaferro S; Morabito S; De Ciocchis A; Cerci S; D'Ambrosio C; Cinotti GA; Scavo D
    Int Urol Nephrol; 1995; 27(4):465-70. PubMed ID: 8586522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma renin activity and plasma aldosterone level in patients with chronic renal failure on maintenance haemodialysis.
    Kuska J; Kokot F
    Acta Med Pol; 1976; 17(3):183-92. PubMed ID: 998330
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma aldosterone during haemodialysis in patients with terminal renal failure].
    Schnurr E; Küppers H; Wiesen K; Grabensee B
    Dtsch Med Wochenschr; 1976 Jul; 101(30):1120, 1125-8. PubMed ID: 1278056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of hypertension in patients with terminal kidney failure on programmed hemodialysis].
    Krimkevich EI; Petrun' NM; Baran EIa; Kutsaĭ NN; Khomenko NV
    Ter Arkh; 1986; 58(8):81-4. PubMed ID: 3020729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 9. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F; Zwahlen A; Favre H; Vallotton M
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renin-angiotensin-aldosterone system in chronic poisoning of rats with lead and cadmium].
    Skoczyńska A
    Med Pr; 1995; 46(3):239-46. PubMed ID: 7565072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renin-angiotensin-aldosterone system in chronic renal failure. Part 2) change of renin-angiotensin-aldosterone system during hemodialysis (author's transl)].
    Fukuchi S; Nakajima K
    Nihon Jinzo Gakkai Shi; 1977 Oct; 19(10):809-14. PubMed ID: 604580
    [No Abstract]   [Full Text] [Related]  

  • 15. The circadian rhythmicity of serum angiotensin converting enzyme: its phasic relation with the circadian cycle of plasma renin and aldosterone.
    Cugini P; Letizia C; Scavo D
    Chronobiologia; 1988; 15(3):229-31. PubMed ID: 2853037
    [No Abstract]   [Full Text] [Related]  

  • 16. Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis.
    Jankova T; Tchankova P; Nenov D
    Nephrol Dial Transplant; 1991; 6 Suppl 3():6-9. PubMed ID: 1663601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of plasma aldosterone in patients on chronic hemodialysis].
    Dordević V; Kostić S; Stefanović V
    Acta Med Iugosl; 1986; 40(1):49-55. PubMed ID: 3515862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aldosteroneia in acute kidney failure].
    Kokot F; Kuska J
    Z Gesamte Inn Med; 1976 Mar; 31(5):144-8. PubMed ID: 936703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.